<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">OJU</journal-id><journal-title-group><journal-title>Open Journal of Urology</journal-title></journal-title-group><issn pub-type="epub">2160-5440</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/oju.2024.144024</article-id><article-id pub-id-type="publisher-id">OJU-132838</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Experience on the Management of Priapism at the Yaounde Central Hospital
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Philip</surname><given-names>Fernandez Owon&amp;#8217;Abessolo</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Jean</surname><given-names>C&amp;#233;dric Fouda</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Armel</surname><given-names>Essomba</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>C&amp;#233;cile</surname><given-names>Etobe</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Achille</surname><given-names>Kpanou Yellem</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Yvon</surname><given-names>Gerard Beling Abanda</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Bright</surname><given-names>Awondo-Che</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Milama</surname><given-names>Steves Ndang Ngou</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib></contrib-group><aff id="aff3"><addr-line>Department of Surgery and Specialty, Faculty of Medicine and Biomedical Sciences, University of Yaound&amp;amp;#233; 1, Yaound&amp;amp;#233;, Cameroon</addr-line></aff><aff id="aff1"><addr-line>Department of Surgery and Specialties, Faculty of Medicine and Pharmaceutical Sciences, University of Douala, Douala, Cameroon</addr-line></aff><aff id="aff2"><addr-line>Urology Service, Yaound&amp;amp;#233; Central Hospital, Yaound&amp;amp;#233;, Cameroon</addr-line></aff><aff id="aff4"><addr-line>Department of Urology, University of Health Sciences, Owendo, Gabon</addr-line></aff><pub-date pub-type="epub"><day>17</day><month>04</month><year>2024</year></pub-date><volume>14</volume><issue>04</issue><fpage>244</fpage><lpage>251</lpage><history><date date-type="received"><day>24,</day>	<month>February</month>	<year>2024</year></date><date date-type="rev-recd"><day>26,</day>	<month>April</month>	<year>2024</year>	</date><date date-type="accepted"><day>29,</day>	<month>April</month>	<year>2024</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  &lt;b&gt;Introduction:&lt;/b&gt; Priapism is a urological emergency defined as a prolonged penile erection for more than 6 hours, painful and sustained, occurring without any sexual stimulation. The diagnosis is essentially clinical. However, the management is often late because of the delay in consultation, which is characteristic in our context. The purpose of our study is to describe the clinical and therapeutic aspects of patients who presented with priapism at the Yaound&amp;#233; Central Hospital as well as to propose a present synthesis concerning the management of priapism. &lt;b&gt;Methodology:&lt;/b&gt; We conducted a descriptive cross-sectional study with a retrospective recruitment method in the urology department of the YCH. It extended over a period of 6 months from January 2022 to June 2022. We reviewed the files of patients seen within a period spanning 10 years from January 1&lt;sup&gt;st&lt;/sup&gt;, 2011 to January 31&lt;sup&gt;st&lt;/sup&gt;, December 2021. The study population consisted of patients who had been hospitalized and treated for priapism. We carried out consecutive and non-exhaustive sampling. &lt;b&gt;Results: &lt;/b&gt;During the study, we collected data from the medical files of 13 patients. The median age was 25 years, with extremes of 12 and 82 years. Most of the patients were between 20 and 30 years old (38.5%). Most of the patients were single (69.2%). Sickle cell disease was the main comorbidity encountered during the study (76.9%). The median time from onset of symptoms to consultation was 10 [6 - 20.5] hours, with extremes of 1 and 264 hours. All patients presented with painful penile erection (100%). There was concomitant multifocal pain in 38.5% of cases suggestive of vaso-occlusive crises (VOC). The symptoms occurred in a non-traumatic context in the majority of cases (92.3%). The T-shunt was the most used surgical technique (84.6%). The median duration of surgery was 36 [35 - 40] minutes with extremes of 25 and 60 minutes, the majority being operated in less than 45 minutes (84.6%). The frequency of postoperative complications was 46.2%, dominated by weak erections/loss of erections (38.5%). The median duration of hospitalisation was 4 [3 - 5.5] days, with extremes 2 and 20 days of hospitalisation. Resumption of sexual activity was reported in 8 patients (61.5%). The time to recovery was mostly greater than 6 weeks (62.5%). &lt;b&gt;Conclusion&lt;/b&gt;&lt;b&gt;:&lt;/b&gt; Priapism remains a urological emergency. The prognosis depends on the patients&amp;#8217; promptness in consulting. The T-Shunt is an effective surgical technique in the event of failure of medical treatment.
 
</p></abstract><kwd-group><kwd>Priapism</kwd><kwd> Treatment</kwd><kwd> Experience</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Priapism is defined as a prolonged penile erection lasting more than 6 hours, often painful and sustained, occurring without any sexual stimulation. It is a serious urological emergency. Its diagnosis is essentially clinical, but treatment is often late due to the delay in consultation. A study conducted by Owon’Abessolo et al. [<xref ref-type="bibr" rid="scirp.132838-ref1">1</xref>] in 2020 revealed that it represented 1.7% of urological emergencies in urban Cameroon. The objective of this study is to describe the clinical and therapeutic aspects of patients with priapism treated at the Yaound&#233; central hospital as well as to present a synthesis concerning the management of priapism in our institution.</p></sec><sec id="s2"><title>2. Materials and Method</title><p>This was a descriptive cross-sectional study with a retrospective recruitment method carried out within the urology department of the YCH. It extended over a recruitment period of 10 years from January 2011 to December 2021. In our study, incorrectly completed files and patients who refused to participate were excluded. The data of each patient were collected and recorded in a data sheet. There was confidentiality of each patient’s information. Subsequently, the data collected was entered and analyzed using SPSS version 23.0 software.</p></sec><sec id="s3"><title>3. Results</title><sec id="s3_1"><title>3.1. Socio-Demographic Characteristics</title><p>The median age was 25 [19.5 - 34] years, with extremes of 12 and 82 years. Most of the patients were between 20 and 30 years old (38.5%). Single people were mostly represented (69.2%) (<xref ref-type="table" rid="table1">Table 1</xref>).</p></sec><sec id="s3_2"><title>3.2. Clinical Features</title><sec id="s3_2_1"><title>3.2.1. History of Priapism</title><p><xref ref-type="fig" rid="fig1">Figure 1</xref> below shows that the frequency of recurrences of priapism was 46.2%, dominated by cases with three recurrences (23.1%).</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Distribution of the population according to socio-demographic characteristics</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Variables</th><th align="center" valign="middle" >Frequency (N = 13)</th><th align="center" valign="middle" >Percentage (%)</th></tr></thead><tr><td align="center" valign="middle" >Age (years)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >&lt;20</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >23.1</td></tr><tr><td align="center" valign="middle" >[20 - 30]</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >38.5</td></tr><tr><td align="center" valign="middle" >[30 - 40]</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >23.1</td></tr><tr><td align="center" valign="middle" >≥40</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >15.4</td></tr><tr><td align="center" valign="middle" >Marital status</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Married</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >30.8</td></tr><tr><td align="center" valign="middle" >Single</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" >69.2</td></tr></tbody></table></table-wrap></sec><sec id="s3_2_2"><title>3.2.2. Surgical History, Comorbidities and Toxicology</title><p>A history of penile surgery was found in 2 patients (15.4%). Sickle cell disease was the main comorbidity encountered during the study (76.9%). With regards to toxicology, the consumption of recreational drugs such as narcotics was frequent in 38.5% of cases (<xref ref-type="table" rid="table2">Table 2</xref>).</p></sec><sec id="s3_2_3"><title>3.2.3. Clinical Signs</title><p>1) Delay in consultation time</p><p>The median time from onset of symptoms to consultation was 10 [6 - 20.5] hours, with extremes of 1 and 264 hours. Most patients came for consultation within 7 to 12 hours (38.5%) as shown in <xref ref-type="fig" rid="fig2">Figure 2</xref> below.</p><p>2) Symptoms and mode of onset</p><p>All cases complained of painful erection (100.0%). It was associated in 38.5% of cases with multifocal pain suggestive of vaso-occlusive crises (VOC). Symptoms occurred in non-traumatic circumstances in the majority of cases (92.3%) (<xref ref-type="table" rid="table3">Table 3</xref>).</p></sec></sec><sec id="s3_3"><title>3.3. Treatment</title><p>In terms of surgical treatment the, T-shunt was the technique utilised in majority</p><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Population distribution according to history of penile surgery, comorbidities and toxicological history</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Variables</th><th align="center" valign="middle" >Frequency (N = 13)</th><th align="center" valign="middle" >Percentage (%)</th></tr></thead><tr><td align="center" valign="middle" >Penile surgery</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >15.4</td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >11</td><td align="center" valign="middle" >84.6</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Comorbidities</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >None</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >15.4</td></tr><tr><td align="center" valign="middle" >Sicke cell disease</td><td align="center" valign="middle" >10</td><td align="center" valign="middle" >76.9</td></tr><tr><td align="center" valign="middle" >Pelvic tumor</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >7.7</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Toxicology</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >narcotics</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >38.5</td></tr></tbody></table></table-wrap><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Distribution of the population according to symptoms and mode of onset</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Variables</th><th align="center" valign="middle" >Frequency (N = 13)</th><th align="center" valign="middle" >Percentage (%)</th></tr></thead><tr><td align="center" valign="middle" >Symptoms</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Painful erection</td><td align="center" valign="middle" >13</td><td align="center" valign="middle" >100.0</td></tr><tr><td align="center" valign="middle" >Multifocal pain</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >38.5</td></tr><tr><td align="center" valign="middle" >Symptom trigger</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Non-traumatic</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >92.3</td></tr><tr><td align="center" valign="middle" >Sexual stimulation</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >7.7</td></tr></tbody></table></table-wrap><p>of the cases (84.6%). The median duration of surgery was 36 [35 - 40] minutes with extremes of 25 and 60 minutes, the majority cases being operated in less than 45 minutes (84.6%). The estimated blood loss was less than 100 ml in most cases (53.8%). The median blood loss being 80 [72.5 - 125] ml with extremes of 50 and 250 ml. Intraoperative blood transfusion was given during surgery in 30.8% of cases (<xref ref-type="table" rid="table4">Table 4</xref>).</p></sec><sec id="s3_4"><title>3.4. Evolution</title><sec id="s3_4_1"><title>3.4.1. Complications</title><p>Post-operative complications occurred in 46.2% of the patients. Loss of erection/weak erection was the most common post-operative complication encountered (38.5%) of cases (<xref ref-type="table" rid="table5">Table 5</xref>).</p></sec><sec id="s3_4_2"><title>3.4.2. Duration of Hospitalisation</title><p>The median length of hospitalization was 4 [3 - 5.5] days, with extremes of 2 and 20 days of hospitalization. The hospital stay of most patients was less than or equal to three days (46.2%) (<xref ref-type="fig" rid="fig3">Figure 3</xref>).</p></sec><sec id="s3_4_3"><title>3.4.3. Evaluation of Sexual Activity</title><p>1) Time to resumption of sexual activity</p><p>Return to sexual activity was documented in 8 patients (61.5%), three had an</p><table-wrap id="table4" ><label><xref ref-type="table" rid="table4">Table 4</xref></label><caption><title> Distribution of the population according to operative events</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Variables</th><th align="center" valign="middle" >Frequency (N = 13)</th><th align="center" valign="middle" >Percentage (%)</th></tr></thead><tr><td align="center" valign="middle" >Surgical means</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >T-shunt</td><td align="center" valign="middle" >11</td><td align="center" valign="middle" >84.6</td></tr><tr><td align="center" valign="middle" >Cavernous puncture</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >15.4</td></tr><tr><td align="center" valign="middle" >Duration of the intervention (in minutes)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >&lt;45</td><td align="center" valign="middle" >11</td><td align="center" valign="middle" >84.6</td></tr><tr><td align="center" valign="middle" >≥45</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >15.4</td></tr><tr><td align="center" valign="middle" >Blood loss (in ml)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >&lt;100</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >53.8</td></tr><tr><td align="center" valign="middle" >≥100</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >46.2</td></tr><tr><td align="center" valign="middle" >Associated processing</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Surgical means</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >30.8</td></tr></tbody></table></table-wrap><table-wrap id="table5" ><label><xref ref-type="table" rid="table5">Table 5</xref></label><caption><title> Distribution of the population according to complications</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Variables</th><th align="center" valign="middle" >Frequency (N = 13)</th><th align="center" valign="middle" >Percentage (%)</th></tr></thead><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >46.2</td></tr><tr><td align="center" valign="middle" >Type of complication</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >53.8</td></tr><tr><td align="center" valign="middle" >Loss of erection/weak erection</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Anemia</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >38.5</td></tr><tr><td align="center" valign="middle" >Surgical site infection</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >15.4</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >15.4</td></tr></tbody></table></table-wrap><p>inabilty to achieve erection (23.1%) and two were not yet sexually active prior to the pathology (15.4%). Among the patients who had resumed sexual activity, the time to resumption was mostly greater than 6 weeks (62.5%), the median being 8 [6 - 8] weeks, with extremes of 6 and 44 weeks (<xref ref-type="table" rid="table6">Table 6</xref>).</p><p>2) Progress of sexual activity over 2 consecutive years</p><p>Sexual activity two years after the management of priapism was favorable in 72.7% of the sexually active patients (<xref ref-type="fig" rid="fig4">Figure 4</xref>).</p><table-wrap id="table6" ><label><xref ref-type="table" rid="table6">Table 6</xref></label><caption><title> Distribution of the population according to postoperative characteristics of sexual activity</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Variables</th><th align="center" valign="middle" >Frequency</th><th align="center" valign="middle" >Percentage (%)</th></tr></thead><tr><td align="center" valign="middle" >Resumption of sexual activity (N = 13)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >61.5</td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >23.1</td></tr><tr><td align="center" valign="middle" >Not concerned*</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >15.4</td></tr><tr><td align="center" valign="middle" >Time to resumption of sexual activity (in weeks) N = 8</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >≤6</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >37.5</td></tr><tr><td align="center" valign="middle" >&gt;6</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >62.5</td></tr></tbody></table></table-wrap><p>*Not sexually active.</p></sec></sec></sec><sec id="s4"><title>4. Discussion</title><sec id="s4_1"><title>4.1. Socio-Demographic Characteristics</title><p>The median age was 25 [19.5 - 34] years, with extremes of 12 and 82 years. Most of the patients were single (69.2%). This could be explained by the fact that priapism occurs more in young people who are single and sexually active. Our findings are similar to those of P A Fall et al. [<xref ref-type="bibr" rid="scirp.132838-ref2">2</xref>] who found an average age of 22.4 years with extremes of 3 and 68 years. In our series all the patients were male, despite the possibility of clitoral priapism as evidenced by a study published by Monllor et al. [<xref ref-type="bibr" rid="scirp.132838-ref3">3</xref>] . This explains the rarity of priapism in women and more particularly in our country where the practice of circumcision is common.</p></sec><sec id="s4_2"><title>4.2. Clinical Characteristics</title><sec id="s4_2_1"><title>4.2.1. History of Priapism</title><p>Although painful and prolonged erection was the main reason for consultation, the history of repeated episodes of spontaneously resolving prolonged erections was also noted. Following history taking, 5 out of 11 patients (46.3%) had episodes of self-limiting prolonged erections in the past. Adjman et al. [<xref ref-type="bibr" rid="scirp.132838-ref4">4</xref>] reported 7 cases of previous episodes for a group of 31 patients (22.5%) and Falandry et al. [<xref ref-type="bibr" rid="scirp.132838-ref5">5</xref>] reported 2 cases out of 26 (7.6%). Thus, it appears that it will be necessary to lay emphasis on the monitoring of patients presenting with prolonged self-limiting erections because of the risk of the occurrence of true priapism.</p></sec><sec id="s4_2_2"><title>4.2.2. History of Surgery, Comorbidities and Toxicology</title><p>Sickle cell disease was the main risk factor encountered during the study (76.9%), followed by the consumption of narcotics in 38.5% of cases. Our findings are similar to those of K. Kamel et al. [<xref ref-type="bibr" rid="scirp.132838-ref6">6</xref>] who found sickle cell disease in 28% of cases, and P.A Fall et al. [<xref ref-type="bibr" rid="scirp.132838-ref2">2</xref>] who reported 46% of patients having sickle cell disease. We explain this by the circumstances of the sickle cell crisis. The sickle-shaped red blood cells do not or barely cross the capillaries, causing thrombosis and stasis which ends in necrosis and then sexual impotence. Priapism is more common in the homozygous form.</p></sec><sec id="s4_2_3"><title>4.2.3. Consultation Period</title><p>The timing and promptness of consultation are decisive for the management and for the prognosis. Most patients came for consultation within 7 to 12 hours (38.5%). This is contrary to findings by Bagayoko Oumar et al. [<xref ref-type="bibr" rid="scirp.132838-ref7">7</xref>] in Mali where Sixty percent (60%) of patients presented late. This difference is accounted for by the fact that discussing issues pertaining to sexual health remains a taboo in Mali. Furthermore, the lack of experienced health care personnel and the circumstances of the onset of the crisis like the consumption of aphrodisiacs keeps patients from consulting within the critical time.</p></sec></sec><sec id="s4_3"><title>4.3. Treatment</title><p>The different modalities of treatment were analyzed. The outcomes were evaluated immediately by the obtention of penile flaccidity, and in the long term by the preservation of erectile function. Complementary surgical treatment was necessary in 11 patients (84.6%) initially treated medically or when consultation was delayed well beyond the 6th hour. The percentage (84.6%) of penile flaccidity obtained immediately after treatment is comparable to Falandry et al. [<xref ref-type="bibr" rid="scirp.132838-ref2">2</xref>] and Adjiman et al. [<xref ref-type="bibr" rid="scirp.132838-ref4">4</xref>] who obtained success in 80.7% and 80% respectively. Despite the relatively long delay in consultation, 11 sexually active patients (72.7%) regained sexual activity two years after surgical management.</p></sec></sec><sec id="s5"><title>5. Conclusion</title><p>Priapism remains a urological emergency. Early consultation and prompt management will inadvertently improve prognosis. Surgical management via the T-shunt technique has proven to be an effective and simple approach, producing commendable results. Medical treatment up to date has not shown any satisfactory results. Surgical treatment seems to be the most logical to avoid tissue damage and reduce the frequency of secondary sexual dysfunction. Despite our small sample size, the analysis of the results obtained in this study permits us to conclude that the effectiveness of the T-shunt, if not the ideal surgical treatment, currently seems to us to be the fastest and most effective technique.</p></sec><sec id="s6"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest regarding the publication of this paper.</p></sec><sec id="s7"><title>Cite this paper</title><p>Owon’Abessolo, P.F., Fouda, J.C., Essomba, A., Etobe, C., Yellem, A.K., Abanda, Y.G.B., Awondo-Che, B. and Ngou, M.S.N. (2024) Experience on the Management of Priapism at the Yaounde Central Hospital. Open Journal of Urology, 14, 244-251. https://doi.org/10.4236/oju.2024.144024</p></sec></body><back><ref-list><title>References</title><ref id="scirp.132838-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Owon&amp;#8217;Abessolo, P.F., Mayopa, C.F., Mekeme, J., Fouda, J.C., Biyouma, M.D.C., Dongmo, G., Angwafor, F. and Sosso, M.A. (2020) Urgences Urologiques: Aspects &amp;#201;pid&amp;#233;miologiques, Cliniques et Th&amp;#233;rapeutiques &amp;#224; l&amp;#8217;H&amp;#244;pital Central de Yaound&amp;#233;. &lt;i&gt;Health Sciences and Disease&lt;/i&gt;, 21, No. 8. &lt;br&gt;http://www.hsd-fmsb.org/</mixed-citation></ref><ref id="scirp.132838-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Fall, S., Diao, A.K., Ndoye, E., Ndiaye Diop, C. and Sylla, S.M. (2005) Gueye et Sa Diagne Le Priapisme: Particularit&amp;#233;s Cliniques et &amp;#233;tiologiques. &lt;i&gt;African Journal of Urology&lt;/i&gt;, 11, 186-190.</mixed-citation></ref><ref id="scirp.132838-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Monllor, J., T&amp;#227;no, F., Arteaga, P.R. and Galbis, F. (1996) Priapism of the Clitoris. &lt;i&gt;European Urology&lt;/i&gt;, 30, 521-522. &lt;br&gt;https://doi.org/10.1159/000474228 </mixed-citation></ref><ref id="scirp.132838-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Adjiman, S., Fava, P., Bitker, M.O. and Chatelain, C. (1988) Priapisme induit par I&amp;#8217;heparine. Un pronostic plus sombre? &lt;i&gt;Annales d&lt;/i&gt;&amp;#8217;&lt;i&gt;Urologie&lt;/i&gt;, 22, 125.</mixed-citation></ref><ref id="scirp.132838-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Falandry, L. (2001) Traitement chirurgical du priapisme par la ponction drainage balanique a &amp;#8220;ciel ouvert&amp;#8221; sur 26 patients de race noire. &lt;i&gt;Annales d&lt;/i&gt;&amp;#8217;&lt;i&gt;Urologie&lt;/i&gt;, 35, 172.&lt;br&gt;https://doi.org/10.1016/S0003-4401(01)00023-7 </mixed-citation></ref><ref id="scirp.132838-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Kamela, K., &lt;i&gt;et al.&lt;/i&gt; (2016) Prise en charge du priapisme &amp;#224; bas d&amp;#233;bit vue tardivement : &amp;#224; propos de 28 cas. &lt;i&gt;African&lt;/i&gt;&lt;i&gt; &lt;/i&gt;&lt;i&gt;Journal&lt;/i&gt;&lt;i&gt; &lt;/i&gt;&lt;i&gt;of&lt;/i&gt;&lt;i&gt; &lt;/i&gt;&lt;i&gt;Urology&lt;/i&gt;&lt;i&gt;, &lt;/i&gt;22, 297-304.&lt;br&gt;https://doi.org/10.1016/j.afju.2015.10.005 </mixed-citation></ref><ref id="scirp.132838-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Oumar, B., &lt;i&gt;et al&lt;/i&gt;&lt;i&gt;.&lt;/i&gt; (2007) Etude du priapisme au service d&amp;#8217;urologie du chu du point &amp;#171;G&amp;#187; &amp;#224; propos de 5 cas. Th&amp;#232;se d&amp;#8217;exercice m&amp;#233;dicale. &lt;br&gt;https://www.bibliosante.ml/handle/123456789/8051</mixed-citation></ref></ref-list></back></article>